Study of AM003 in Patients With Locally Advanced and Metastatic Solid Tumors
Clinical trial NCT06258330 · COMPLETED
Trial details
- NCT number
- NCT06258330
- Sponsor
- Aummune Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-22
- Primary completion
- 2024-07-07
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.